中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
高能物理研究所 [310]
上海药物研究所 [182]
近代物理研究所 [162]
昆明植物研究所 [83]
大连化学物理研究所 [79]
化学研究所 [76]
更多
采集方式
OAI收割 [1813]
iSwitch采集 [339]
内容类型
期刊论文 [2101]
会议论文 [35]
EI期刊论文 [6]
CNKI期刊论文 [2]
SCI/SSCI论文 [2]
专著 [2]
更多
发表日期
2025 [14]
2024 [35]
2023 [50]
2022 [102]
2021 [128]
2020 [107]
更多
学科主题
Plant Sci... [31]
Physics [27]
Chemistry [25]
Biochemis... [20]
Science &... [15]
Pharmacol... [13]
更多
筛选
浏览/检索结果:
共2152条,第1-10条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
作者升序
作者降序
Recent advances in traditional Chinese medicine metabolism: Sample pre-treatment, MS-oriented analytical strategies and typical applications
期刊论文
OAI收割
TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 2025, 卷号: 189, 页码: 22
作者:
Hong, Li-li
;
Cui, Dian-xin
;
Wang, Hong-da
;
Jing, Qi
;
Li, Xue
  |  
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2025/06/23
Traditional Chinese medicine metabolism
Bio-samples pre-treatment
Mass spectrometry
Data acquisition
Data processing
Application
Two-dimensional Pt@g-C3N4/ReS2 Van Der Waals Heterostructure for photocatalytic hydrogen evolution with direct
Z
-scheme
期刊论文
OAI收割
CHEMICAL PHYSICS LETTERS, 2025, 卷号: 870, 页码: 142101
作者:
Wang, Hong-Yao
;
Yang, Chuan-Lu
;
Li, Xiaohu
;
Liu, Yuliang
;
Zhao, Wenkai
  |  
收藏
  |  
浏览/下载:1/0
  |  
提交时间:2025/07/07
Heterostructure
Photocatalytic
Direct Z -scheme
Solar-to-hydrogen
Gibbs free energy
Gravitational wave astronomy with TianQin
期刊论文
OAI收割
REPORTS ON PROGRESS IN PHYSICS, 2025, 卷号: 88, 期号: 5
作者:
Li, En-Kun
;
Liu, Shuai
;
Torres-Orjuela, Alejandro
;
Chen, Xian
;
Inayoshi, Kohei
  |  
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2025/05/26
gravitational wave
astronomy
TianQin
A Mitochondrion-Targeted NIR-II Modulator for Synergistic Ferroptosis-Immunotherapy
期刊论文
OAI收割
SMALL, 2025, 页码: 13
作者:
Wang, Miao
;
Ding, Qihang
;
Su, Wuyue
;
Luo, Min
;
Yang, Runping
  |  
收藏
  |  
浏览/下载:0/0
  |  
提交时间:2025/06/23
antitumor immunity activity
ferroptosis
immunogenic cell death
mitochondria targeting
NIR-II modulator
Jatrophane and ingenane diterpenoids with anti-inflammatory activity from
Euphorbia esula
期刊论文
OAI收割
PHYTOCHEMISTRY, 2025, 卷号: 232, 页码: 13
作者:
Li, Yu-Peng
;
Li, Ying
;
Gao, Wen-Jing
;
Fang, Chu-Hong
;
Lv, Ming-Jun
  |  
收藏
  |  
浏览/下载:61/0
  |  
提交时间:2025/04/01
Euphorbia esula L.
Euphorbiaceae
Diterpenoid
Anti-inflammatory
NF-kappa B/MAPK
Nrf2/HO-1
Alstolarsines A-E, Indoline Alkaloids with Two Different Carbon Skeletons from
Alstonia scholaris
期刊论文
OAI收割
JOURNAL OF NATURAL PRODUCTS, 2025, 卷号: 88, 期号: 3, 页码: 815-820
作者:
Zhu, Xu-Xin
;
Fan, Yao-Yue
;
Zheng, Cheng-Yu
;
Yang, Hong-Ying
;
Gao, Kun
  |  
收藏
  |  
浏览/下载:0/0
  |  
提交时间:2025/05/27
Deep Learning Enhanced Near Infrared-II Imaging and Image-Guided Small Interfering Ribonucleic Acid Therapy of Ischemic Stroke
期刊论文
OAI收割
ACS NANO, 2025, 卷号: 19, 期号: 10, 页码: 10323-10336
作者:
Yu, Kai
;
Fu, Lidan
  |  
收藏
  |  
浏览/下载:0/0
  |  
提交时间:2025/04/24
ischemic stroke
small interferingRNA therapy
near-infrared II imaging
blood-brainbarrier
deep learning
Discovery of Covalent and Cell-Active ALKBH5 Inhibitors with Potent Antileukemia Effects
In Vivo
期刊论文
OAI收割
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2025, 页码: 9
作者:
  |  
收藏
  |  
浏览/下载:1/0
  |  
提交时间:2025/04/24
RNA epigenetics
N
(6)-methyladenosine
ALKBH5
covalent inhibitor
antileukemia
Terrestrial ecosystem response to Early Cretaceous global environmental change: A calibrated, high-resolution Aptian record from Northeast China
期刊论文
OAI收割
EARTH AND PLANETARY SCIENCE LETTERS, 2025, 卷号: 653, 页码: 13
作者:
Sun, Ming-Dao
;
Lin, Qin
;
Ramezani, Jahandar
;
Liu, Jiang-Si
;
Lu, Zheng-An
  |  
收藏
  |  
浏览/下载:22/0
  |  
提交时间:2025/04/03
Early Cretaceous
Aptian
CA-ID-TIMS geochronology
Astrochronology
Carbon isotope stratigraphy
A patent review of BRD4 inhibitors (2020-present)
期刊论文
OAI收割
EXPERT OPINION ON THERAPEUTIC PATENTS, 2025, 页码: 16
作者:
Chen, Yanfang
;
Zhou, Huanmin
;
Yu, Jiamin
;
Gao, Jing
;
Xue, Shengyu
  |  
收藏
  |  
浏览/下载:9/0
  |  
提交时间:2025/04/01
BET
BRD4
inhibitor
cancer treatment
selectivity